Trustedgecapital (532056)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a small discount to book value: P/B 0.99 (₹23.10 vs ₹23.31)
• Tiny ₹11 Cr market cap could be neglected and inefficiently priced
• ROCE is marginally positive at 1.05% despite negative ROE
• Sales growth of 385% shows some commercial activity, albeit from a negligible ₹1 Cr base

Concerns

• Zero net profit and negative ROE of -1.86% mean the asset base is not earning its keep
• Price of ₹23.10 is far below the stated 52-week low of ₹78.00, implying either severe deterioration or suspect data
• Piotroski F-score of 4/9 points to weak financial health
• No dividend and no promoter holding disclosure leave minority investors without income or visibility on insider alignment

AI Analysis

Let’s start with what I can see. Trustedgecapital is a ₹11 crore shell of a company, trading at ₹23.10 against a book value of ₹23.31. That is a price-to-book of 0.99, so the market is offering me a rupee of net assets for roughly a rupee. Graham would smile at that discipline, but only if those assets earn decent returns. They don't. ROE is -1.86%, ROCE is 1.05%, and the latest quarter produced net profit of zero. A company with a negative return on equity is destroying value, not compounding it. The reported sales growth of 385% is meaningless because the base is tiny—latest quarter sales are just ₹1 crore. I cannot build an investment thesis on that. This is an investment company, so moats are scarce. There is no pricing power, no brand, no unique product. The so-called asset play only works if book value is real and eventually unlocks value. With a Piotroski F-score of 4 out of 9, financial health is weak. I also notice the current market price is far below the stated 52-week range of ₹78 to ₹178.50. That anomaly makes me suspicious—either the data is wrong or the business has collapsed faster than the range updated. There is no dividend, and promoter holding is not available, so I cannot judge whether management is aligned with me. A very cheap price is not enough. If the assets are truly worth book value, this could be a Graham special, but with zero earnings and negative ROE, time is not my friend. I would want to see a credible plan to raise ROE, real evidence that book value is being maintained, and a catalyst such as a buyback, dividend, or asset sale. Until then, this is an intriguing balance sheet, not a business I would buy today.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer